149 related articles for article (PubMed ID: 17054913)
1. Inhibition of LXRalpha signaling by vitamin D receptor: possible role of VDR in bile acid synthesis.
Jiang W; Miyamoto T; Kakizawa T; Nishio SI; Oiwa A; Takeda T; Suzuki S; Hashizume K
Biochem Biophys Res Commun; 2006 Dec; 351(1):176-84. PubMed ID: 17054913
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of peroxisome proliferator-activated receptor alpha signaling by vitamin D receptor.
Sakuma T; Miyamoto T; Jiang W; Kakizawa T; Nishio SI; Suzuki S; Takeda T; Oiwa A; Hashizume K
Biochem Biophys Res Commun; 2003 Dec; 312(2):513-9. PubMed ID: 14637167
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer.
Gbaguidi GF; Agellon LB
Nucleic Acids Res; 2004; 32(3):1113-21. PubMed ID: 14960721
[TBL] [Abstract][Full Text] [Related]
6. A novel bile acid-activated vitamin D receptor signaling in human hepatocytes.
Han S; Li T; Ellis E; Strom S; Chiang JY
Mol Endocrinol; 2010 Jun; 24(6):1151-64. PubMed ID: 20371703
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.
Lu TT; Makishima M; Repa JJ; Schoonjans K; Kerr TA; Auwerx J; Mangelsdorf DJ
Mol Cell; 2000 Sep; 6(3):507-15. PubMed ID: 11030331
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
[TBL] [Abstract][Full Text] [Related]
10. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
Bramlett KS; Yao S; Burris TP
Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
[TBL] [Abstract][Full Text] [Related]
11. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
13. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha.
Goodwin B; Watson MA; Kim H; Miao J; Kemper JK; Kliewer SA
Mol Endocrinol; 2003 Mar; 17(3):386-94. PubMed ID: 12554795
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha).
Chiang JY; Kimmel R; Stroup D
Gene; 2001 Jan; 262(1-2):257-65. PubMed ID: 11179691
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol potentiates vitamin D and nuclear receptor signaling.
Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
[TBL] [Abstract][Full Text] [Related]
17. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
Herdick M; Carlberg C
J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
[TBL] [Abstract][Full Text] [Related]
18. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.
Raval-Pandya M; Dhawan P; Barletta F; Christakos S
Mol Endocrinol; 2001 Jun; 15(6):1035-46. PubMed ID: 11376120
[TBL] [Abstract][Full Text] [Related]
19. The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity.
Ourlin JC; Lasserre F; Pineau T; Fabre JM; Sa-Cunha A; Maurel P; Vilarem MJ; Pascussi JM
Mol Endocrinol; 2003 Sep; 17(9):1693-703. PubMed ID: 12805410
[TBL] [Abstract][Full Text] [Related]
20. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
